Carrizo GE, Lin P, Lee SH, Shenderov K, Blériot C, Cha M, Schimmelpfennig L, Shen Z, van Teijlingen Bakker N, Grzes KM, Kelly B, Safinia N, Schole KL, Musa Y, Mittler G, Zen Y, Pearce EJ, Ginhoux F, Sanin DE, Puleston DJ, Pearce EL., 2026, The transition from monocyte to tissue-resident macrophage requires DHPS, Nature, 651(8106):763-774. doi: 10.1038/s41586-025-09972-2. PMCID: PMC12999486  PubMed

Saba JA, Huang Z, Schole KL, Ye X, Bhatt SD, Li Y, Timp W, Cheng J, Green R., 2024, LARP1 binds ribosomes and TOP mRNAs in repressed complexes, EMBO J., 43(24):6555-6572. doi: 10.1038/s44318-024-00294-z. PMCID: PMC11649897  PubMed

Saba JA, Huang Z, Schole KL, Ye X, Bhatt SD, Li Y, Timp W, Cheng J, Green R., 2023, LARP1 senses free ribosomes to coordinate supply and demand of ribosomal proteins, bioRxiv, 2023.11.01.565189. doi: 10.1101/2023.11.01.565189, PMCID: PMC10635049  PubMed

Reyes Gaido OE, Pavlaki N, Granger JM, Mesubi OO, Liu B, Lin BL, Long A, Walker D, Mayourian J, Schole KL, Terrillion CE, Nkashama LJ, Hulsurkar MM, Dorn LE, Ferrero KM, Huganir RL, Müller FU, Wehrens XHT, Liu JO, Luczak ED, Bezzerides VJ, Anderson ME., 2023, An improved reporter identifies ruxolitinib as a potent and cardioprotective CaMKII inhibitor, Sci Transl Med., 15(701):eabq7839. doi: 10.1126/scitranslmed.abq7839, PMID: 37343080  PubMed

Gaido OER, Nkashama LJ, Schole KL, Wang Q, Umapathi P, Mesubi OO, Konstantinidis K, Luczak ED, Anderson ME., 2022, CaMKII as a Therapeutic Target in Cardiovascular Disease, Annu Rev Pharmacol Toxicol., doi: 10.1146/annurev-pharmtox-051421-111814. PMID: 35973713  PubMed